Cargando…

Immunological detection of faecal occult blood in colorectal cancer.

A new two-phase test kit for faecal occult blood combining a sensitive guaiac test (Fecatwin (S)ensitive) with an immunological test for human haemoglobin (FECA-EIA) was compared with three current guaiac tests (Fecatest, Fecatwin, Haemoccult) in 19 colorectal cancer patients and 11 controls on a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Turunen, M. J., Liewendahl, K., Partanen, P., Adlercreutz, H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1984
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976692/
https://www.ncbi.nlm.nih.gov/pubmed/6696817
_version_ 1782135108158881792
author Turunen, M. J.
Liewendahl, K.
Partanen, P.
Adlercreutz, H.
author_facet Turunen, M. J.
Liewendahl, K.
Partanen, P.
Adlercreutz, H.
author_sort Turunen, M. J.
collection PubMed
description A new two-phase test kit for faecal occult blood combining a sensitive guaiac test (Fecatwin (S)ensitive) with an immunological test for human haemoglobin (FECA-EIA) was compared with three current guaiac tests (Fecatest, Fecatwin, Haemoccult) in 19 colorectal cancer patients and 11 controls on a restricted diet. A total of 43 48 h faecal samples (30 from cancer patients and 13 from controls) were collected for quantitative determination of faecal blood loss with the 51Cr method. Qualitative testing revealed that FECA-EIA was the most sensitive test, giving one (3%) false negative test result in the 30 tests on colorectal cancer patients and no false positives in the control subjects. It was also the only test that detected low-degree tumour bleeding. Fecatest and Fecatwin S were the most sensitive guaiac tests, giving 7 and 10% false negative test results, respectively, in the 30 colorectal cancer samples, whereas Haemoccult and Fecatwin gave 23% false negative test results. For screening purposes and in order to reduce costs it is suggested that only the positive test results of the very sensitive guaiac test (Fecatwin S) should be tested with the FECA-EIA test to eliminate false positive results. With this approach the diagnostic accuracy of the new two-phase test will be about twice as good as for the Haemoccult test.
format Text
id pubmed-1976692
institution National Center for Biotechnology Information
language English
publishDate 1984
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19766922009-09-10 Immunological detection of faecal occult blood in colorectal cancer. Turunen, M. J. Liewendahl, K. Partanen, P. Adlercreutz, H. Br J Cancer Research Article A new two-phase test kit for faecal occult blood combining a sensitive guaiac test (Fecatwin (S)ensitive) with an immunological test for human haemoglobin (FECA-EIA) was compared with three current guaiac tests (Fecatest, Fecatwin, Haemoccult) in 19 colorectal cancer patients and 11 controls on a restricted diet. A total of 43 48 h faecal samples (30 from cancer patients and 13 from controls) were collected for quantitative determination of faecal blood loss with the 51Cr method. Qualitative testing revealed that FECA-EIA was the most sensitive test, giving one (3%) false negative test result in the 30 tests on colorectal cancer patients and no false positives in the control subjects. It was also the only test that detected low-degree tumour bleeding. Fecatest and Fecatwin S were the most sensitive guaiac tests, giving 7 and 10% false negative test results, respectively, in the 30 colorectal cancer samples, whereas Haemoccult and Fecatwin gave 23% false negative test results. For screening purposes and in order to reduce costs it is suggested that only the positive test results of the very sensitive guaiac test (Fecatwin S) should be tested with the FECA-EIA test to eliminate false positive results. With this approach the diagnostic accuracy of the new two-phase test will be about twice as good as for the Haemoccult test. Nature Publishing Group 1984-02 /pmc/articles/PMC1976692/ /pubmed/6696817 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Turunen, M. J.
Liewendahl, K.
Partanen, P.
Adlercreutz, H.
Immunological detection of faecal occult blood in colorectal cancer.
title Immunological detection of faecal occult blood in colorectal cancer.
title_full Immunological detection of faecal occult blood in colorectal cancer.
title_fullStr Immunological detection of faecal occult blood in colorectal cancer.
title_full_unstemmed Immunological detection of faecal occult blood in colorectal cancer.
title_short Immunological detection of faecal occult blood in colorectal cancer.
title_sort immunological detection of faecal occult blood in colorectal cancer.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976692/
https://www.ncbi.nlm.nih.gov/pubmed/6696817
work_keys_str_mv AT turunenmj immunologicaldetectionoffaecaloccultbloodincolorectalcancer
AT liewendahlk immunologicaldetectionoffaecaloccultbloodincolorectalcancer
AT partanenp immunologicaldetectionoffaecaloccultbloodincolorectalcancer
AT adlercreutzh immunologicaldetectionoffaecaloccultbloodincolorectalcancer